Genelabs Technologies, Inc. Reports Results for the Second Quarter and First Six Months of 2008

Published: Aug 12, 2008

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases, reported financial results for the second quarter and six months ended June 30, 2008.

Back to news